Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shamzah Araf, Koorosh Korfi, Tahrima Rahim, Andrew Davies & Jude Fitzgibbon. (2016) Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine. Expert Review of Molecular Diagnostics 16:10, pages 1093-1102.
Read now
Read now
Luis F Porrata, David J Inwards, Stephen M Ansell, Ivana N Micallef, Patrick B Johnston, William J Hogan & Svetomir N Markovic. (2015) Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma. Journal of Blood Medicine 6, pages 45-53.
Read now
Read now
Luis F. Porrata, Kay M. Ristow, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz Nowakowski, Carrie A. Thompson & Svetomir N. Markovic. (2014) Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:12, pages 2728-2738.
Read now
Read now
Mary J. Ninan, Punit D. Wadhwa & Pankaj Gupta. (2011) Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leukemia & Lymphoma 52:3, pages 360-373.
Read now
Read now
Heiner Adams, Florian R Fritzsche, Stephan Dirnhofer, Glen Kristiansen & Alexandar Tzankov. (2010) Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma. Expert Opinion on Therapeutic Targets 14:6, pages 577-584.
Read now
Read now
Articles from other publishers (71)
Luis F. Porrata, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Urshila Durani & Svetomir N. Markovic. (2023)
Day 100 Natural Killer Cell/CD14+HLA‐DR
DIM
ratio and survival in lymphoma post‐autologous peripheral blood hematopoietic stem cell transplantation
. Clinical Transplantation.
Crossref
Crossref
Snezana Sretenovic & Predrag Djurdjevic. (2022) High-grade B-cell lymphoma. Medicinski pregled Medical review 75:Suppl. 1, pages 88-95.
Crossref
Crossref
Corinna Lang-Schwarz, Balint Melcher, Theresa Dregelies, Zahra Norouzzadeh, Stefanie Rund-Küffner, Klaus Lang-Schwarz, Michael Vieth & William Sterlacci. (2021) Adjuvant chemotherapy in stage II and III colon cancer: the role of the “budding and TILs-(tumor-infiltrating lymphocytes) combination” as tumor-host antagonists. International Journal of Colorectal Disease 36:8, pages 1765-1779.
Crossref
Crossref
Magdalena M. Brune, Georg Stüssi, Pontus Lundberg, Visar Vela, Dominik Heim, Markus G. Manz, Eugenia Haralambieva, Thomas Pabst, Yara Banz, Mario Bargetzi, Rainer Grobholz, Martin Fehr, Sergio Cogliatti, Gert J. Ossenkoppele, Bob Löwenberg, Christina Biaggi Rudolf, Qiyu Li, Jakob Passweg, Luca Mazzuchelli, Michael Medinger & Alexandar Tzankov. (2021) Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Annals of Hematology 100:5, pages 1169-1179.
Crossref
Crossref
Elizabeth Punnoose, Franklin V. Peale, Edith Szafer-Glusman, Guiyuan Lei, Richard Bourgon, An D. Do, Eugene Kim, Liping Zhang, Pedro Farinha, Randy D. Gascoyne, F. Javier Munoz, Maurizio Martelli, Anja Mottok, Gilles A. Salles, Laurie H. Sehn, John F. Seymour, Marek Trnĕný, Mikkel Z. Oestergaard, Kirsten E. Mundt & Umberto Vitolo. (2021) BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis. Clinical Lymphoma Myeloma and Leukemia 21:4, pages 267-278.e10.
Crossref
Crossref
Rachel E. Crossland, Jean Norden, Sakhila Ghimire, Mateja Kralj Juric, Kim F. Pearce, Clare Lendrem, Matthew Collin, Eva Mischak-Weissinger, Ernst Holler, Hildegard T. Greinix & Anne M. Dickinson. (2021) Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease. Frontiers in Immunology 12.
Crossref
Crossref
Isabelle C. Arnold, Mariela Artola-Boran, Alessandra Gurtner, Katrin Bertram, Michael Bauer, Ziva Frangez, Burkhard Becher, Manfred Kopf, Shida Yousefi, Hans-Uwe Simon, Alexandar Tzankov & Anne Müller. (2020) The GM-CSF–IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses. Journal of Experimental Medicine 217:12.
Crossref
Crossref
Anna Szumera‐Ciećkiewicz, Grzegorz Rymkiewicz, Kamil Sokół, Ewa Paszkiewicz‐Kozik, Anita Borysiuk, Jan Poleszczuk, Katarzyna Bachnio, Zbigniew Bystydzienski, Renata Woroniecka, Beata Grygalewicz, Martyna Kotarska, Monika Stańczak, Daria Owczarek, Beata Pytlak, Monika Prochorec‐Sobieszek & Jan Walewski. (2020)
Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of
BCL2
and
BCL6
rearrangements
. International Journal of Laboratory Hematology 42:4, pages 453-463.
Crossref
Crossref
С.М. Гайдукова, С.В. Выдыборец, Т.П. Перехрестенко, О.В. Кучер, Г.И. Мороз & Ю.Ю. Попович. (2020) Epidemiology, Pathogenesis, Molecular Characteristics, Classification, and Prognosis of Diffuse Large B-Cell Lymphoma:New Views on the Existing Problems. Гематология. Трансфузиология. Восточная Европа:2, pages 217-225.
Crossref
Crossref
Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas & Svetomir N. Markovic. (2019) Autograft immune content and survival in non-Hodgkin’s lymphoma: A post hoc analysis. Leukemia Research 81, pages 1-9.
Crossref
Crossref
Siraj M. El Jamal, Zakaria Grada, Mohamed H. El Dinali, He Zhou, Sofie-Yasmin Hassan, Ali G. Saad, Bradley Gibson, Xinchun Zhou, Hend A. Abulsayen, Helmi S. Khadra, Jessica Friedman, Hosam Shalaby, Abida Kadi, Mosaad Megahed, Myesa Emberesh, Julie Teruya-Feldstein, Adolfo Firpo-Betancourt, Youssef Haikel, Mostafa Fraig & Mohamed Hassan. (2019) MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type. Laboratory Investigation 99:4, pages 539-550.
Crossref
Crossref
Monica Bianchi, Dominik Heim, Claudia Lengerke, Jörg Halter, Sabine Gerull, Martina Kleber, Dimitrios A. Tsakiris, Jakob Passweg, Alexandar Tzankov & Michael Medinger. (2018) Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Annals of Hematology 98:4, pages 971-977.
Crossref
Crossref
С. М. Гайдукова, С. В. Видиборець & Ю. Ю. Попович. (2018) Epidemiology, pathogenesis, molecular characteristics, classification and prognosis of the diffuse large B-cell lymphoma. Family medicine:5, pages 36-40.
Crossref
Crossref
Corinna Lang-Schwarz, Balint Melcher, Franziska Haumaier, Klaus Lang-Schwarz, Thomas Rupprecht, Michael Vieth & William Sterlacci. (2018) Budding and tumor—infiltrating lymphocytes — combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups. Human Pathology 79, pages 160-167.
Crossref
Crossref
A Kansagra, D J Inwards, S M Ansell, I N Micallef, P B Johnston, W J Hogan, S N Markovic & L F Porrata. (2017) Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation. Bone Marrow Transplantation 53:2, pages 146-154.
Crossref
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Ryan T. Phan. 2018. Atlas of Hematopathology. Atlas of Hematopathology
557
570
.
Rachel E. Crossland, Jean Norden, Mateja Kralj Juric, Kim F. Pearce, Clare Lendrem, Louis A. Bibby, Matthew Collin, Hildegard T. Greinix & Anne M. Dickinson. (2017) Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease. Frontiers in Immunology 8.
Crossref
Crossref
Asif Ali, Sarah Bell, Alan Bilsland, Jill Slavin, Victoria Lynch, Maha Elgoweini, Mohammad H. Derakhshan, Nigel B. Jamieson, David Chang, Victoria Brown, Simon Denley, Clare Orange, Colin McKay, Ross Carter, Karin A. Oien & Fraser R. Duthie. (2017) Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer Agreement. Applied Immunohistochemistry & Molecular Morphology 25:9, pages 599-608.
Crossref
Crossref
William Sterlacci, Michael Fiegl, Mathias Gugger, Lukas Bubendorf, Spasenija Savic & Alexandar Tzankov. (2017) MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLC. Virchows Archiv 471:1, pages 49-55.
Crossref
Crossref
Shujuan Zhou, Linglong Xu, Yongyong Ma, Liyuan Tang, Yu Zhang, Yifen Shi, Lan Sun, Yi Chen, Bin Liang, Yuhong Zhou, Kang Yu & Jianping Shen. (2017) Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma. Oncotarget 8:12, pages 19556-19565.
Crossref
Crossref
So-Woon Kim, Jin Roh & Chan-Sik Park. (2016) Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips. Journal of Pathology and Translational Medicine 50:6, pages 411-418.
Crossref
Crossref
William Sterlacci, Shereen Saker, Bettina Huber, Michael Fiegl & Alexandar Tzankov. (2016) Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung. Virchows Archiv 468:4, pages 463-471.
Crossref
Crossref
L Deng, Z Y Xu-Monette, S Loghavi, G C Manyam, Y Xia, C Visco, J Huh, L Zhang, Q Zhai, Y Wang, L Qiu, K Dybkær, A Chiu, A M Perry, S Zhang, A Tzankov, H Rao, J Abramson, A R Sohani, M Xu, E D Hsi, J Zhu, M Ponzoni, S Wang, Ling Li, M Zhang, A J M Ferreri, B M Parsons, Y Li, M A Piris, L J Medeiros & K H Young. (2015) Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Leukemia 30:2, pages 361-372.
Crossref
Crossref
Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, William J. Hogan & Svetomir N. Markovic. (2015) Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation. Journal of Hematology & Oncology 8:1.
Crossref
Crossref
Alexandar Tzankov, Nora Leu, Simone Muenst, Darius Juskevicius, Dirk Klingbiel, Christoph Mamot & Stephan Dirnhofer. (2015) Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study. Journal of Hematology & Oncology 8:1.
Crossref
Crossref
M Medinger, W Krenger, A Jakab, J Halter, A Buser, C Bucher, J Passweg & A Tzankov. (2015) Numerical impairment of nestin+ bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML. Bone Marrow Transplantation 50:11, pages 1453-1458.
Crossref
Crossref
Thomas Menter, Anjes Gasser, Darius Juskevicius, Stephan Dirnhofer & Alexandar Tzankov. (2015) Diagnostic Utility of the Germinal Center–associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. Applied Immunohistochemistry & Molecular Morphology 23:7, pages 491-498.
Crossref
Crossref
Geoffrey Pomme, Florian Augustin, Michael Fiegl, Raoul A. Droeser, William Sterlacci & Alexandar Tzankov. (2015) Detailed assessment of microvasculature markers in non-small cell lung cancer reveals potentially clinically relevant characteristics. Virchows Archiv 467:1, pages 55-66.
Crossref
Crossref
Thomas Menter, Stephan Dirnhofer & Alexandar Tzankov. (2015) LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma. Journal of Clinical Pathology 68:6, pages 473-478.
Crossref
Crossref
Florian Augustin, Michael Fiegl, Thomas Schmid, Geoffrey Pomme, William Sterlacci & Alexandar Tzankov. (2015) Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer. Journal of Clinical Pathology 68:5, pages 368-373.
Crossref
Crossref
Sylvia Hoeller, Alexandar Tzankov, Frank Stenner & Stephan Dirnhofer. (2015) When and how to test for C-MYC in aggressive B cell lymphomas. Journal of Hematopathology 8:1, pages 13-20.
Crossref
Crossref
Michael Hale & Scott Patterson. 2014. Clinical Trial Biostatistics and Biopharmaceutical Applications. Clinical Trial Biostatistics and Biopharmaceutical Applications
453
496
.
Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, William J. Hogan & Svetomir N. Markovic. (2014) Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation 20:11, pages 1804-1812.
Crossref
Crossref
Alexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, Carlo Visco, Stephan Dirnhofer, Nora Gisin, Karen Dybkaer, Attilio Orazi, Govind Bhagat, Kristy L Richards, Eric D Hsi, William WL Choi, J Han van Krieken, Maurilio Ponzoni, Andrés JM Ferreri, Qing Ye, Jane N Winter, John P Farnen, Miguel A Piris, Michael B Møller, M James You, Timothy McDonnell, L Jeffrey Medeiros & Ken H Young. (2014) Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Modern Pathology 27:7, pages 958-971.
Crossref
Crossref
Miaoxia He, Li Gao, Shimin Zhang, Liyang Tao, Jianjun Wang, Jianmin Yang & Minghua Zhu. (2013) Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. Gastric Cancer 17:3, pages 431-441.
Crossref
Crossref
Shogo Kumagai, Masaharu Tashima, Jun Fujikawa, Makoto Iwasaki, Yoshihiro Iwamoto, Yuki Sueki, Akiko Fukunaga, Soshi Yanagita, Momoko Nishikori, Akifumi Takaori-Kondo & Nobuyoshi Arima. (2014) Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma. International Journal of Hematology 99:6, pages 737-742.
Crossref
Crossref
Anamarija M. Perry, Yuridia Alvarado-Bernal, Javier A. Laurini, Lynette M. Smith, Graham W. Slack, King L. Tan, Laurie H. Sehn, Kai Fu, Patricia Aoun, Timothy C. Greiner, Wing C. Chan, Philip J. Bierman, Robert G. Bociek, James O. Armitage, Julie M. Vose, Randy D. Gascoyne & Dennis D. Weisenburger. (2014) MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab. British Journal of Haematology 165:3, pages 382-391.
Crossref
Crossref
Yan-Li Li, Yue-Yin Pan, Yang Jiao, Jie Ning, Yin-Guang Fan & Zhi-Min Zhai. (2013) Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. Annals of Hematology 93:4, pages 617-626.
Crossref
Crossref
Willam Sterlacci, Spasenija Savic, Michael Fiegl, Ellen Obermann & Alexandar Tzankov. (2014) Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization. Journal of Thoracic Oncology 9:1, pages 41-49.
Crossref
Crossref
Rachel E Culpin, Michal Sieniawski, Brian Angus, Geetha K Menon, Stephen J Proctor, Paul Milne, Kate McCabe & Tryfonia Mainou-Fowler. (2013) Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients. Histopathology 63:6, pages 788-801.
Crossref
Crossref
E Frei, C Visco, Z Y Xu-Monette, S Dirnhofer, K Dybkær, A Orazi, G Bhagat, E D Hsi, J H van Krieken, M Ponzoni, R S Go, M A Piris, M B Møller, K H Young & A Tzankov. (2013) Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma. Journal of Clinical Pathology 66:11, pages 956-961.
Crossref
Crossref
Ahmad A. AbdulMajeed, Andrew J. Dalley & Camile S. Farah. (2013) Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma. Journal of Oral Pathology & Medicine 42:10, pages 755-760.
Crossref
Crossref
A Tefferi, E Rumi, G Finazzi, H Gisslinger, A M Vannucchi, F Rodeghiero, M L Randi, R Vaidya, M Cazzola, A Rambaldi, B Gisslinger, L Pieri, M Ruggeri, I Bertozzi, N H Sulai, I Casetti, A Carobbio, G Jeryczynski, D R Larson, L Müllauer, A Pardanani, J Thiele, F Passamonti & T Barbui. (2013) Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia 27:9, pages 1874-1881.
Crossref
Crossref
Ahmad A. AbdulMajeed, Andrew J. Dalley & Camile S. Farah. (2013) Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. Annals of Diagnostic Pathology 17:4, pages 331-340.
Crossref
Crossref
Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, William J. Hogan & Svetomir N. Markovic. (2013) Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation. Bone Marrow Research 2013, pages 1-8.
Crossref
Crossref
Yuan Mao, Mei Ping Lu, Hong Lin, Da Wei Zhang, Ying Liu, Qing Dong Li, Zhi Gang Lv, Jia Ren Xu, Ren Jie Chen & Jin Zhu. (2013) Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies. PLoS ONE 8:4, pages e60313.
Crossref
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Wayne W. Grody. 2013. Atlas of Hematopathology. Atlas of Hematopathology
427
438
.
Pauline Brice & Catherine ThieblemontC. Thieblemont, M. D. Venon, C. Benet, J. Brière & N. Mounier. 2013. Actualités thérapeutiques dans les lymphomes. Actualités thérapeutiques dans les lymphomes
65
81
.
R. Eric Davis. 2013. Lymphoma. Lymphoma
35
51
.
Young Wha Koh, Hyo Jeong Kang, Chansik Park, Dok Hyun Yoon, Shin Kim, Cheolwon Suh, Ji Eun Kim, Chul-Woo Kim & Jooryung Huh. (2012) Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin Lymphoma. American Journal of Clinical Pathology 138:6, pages 846-854.
Crossref
Crossref
Nathalie A. JohnsonGraham W. SlackKerry J. SavageJoseph M. ConnorsSusana Ben-NeriahSanja RogicDavid W. ScottKing L. TanChristian SteidlLaurie H. SehnWing C. ChanJaveed IqbalPaul N. MeyerGeorg LenzGeorge WrightLisa M. RimszaCarlo ValentinoPatrick BrunhoeberThomas M. GroganRita M. BrazielJames R. CookRaymond R. TubbsDennis D. WeisenburgerElias CampoAndreas RosenwaldGerman OttJan DelabieChristina HolcroftElaine S. JaffeLouis M. StaudtRandy D. Gascoyne. (2012) Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. Journal of Clinical Oncology 30:28, pages 3452-3459.
Crossref
Crossref
C Visco, Y Li, Z Y Xu-Monette, R N Miranda, T M Green, Y Li, A Tzankov, W Wen, W-m Liu, B S Kahl, E S G d'Amore, S Montes-Moreno, K Dybkær, A Chiu, W Tam, A Orazi, Y Zu, G Bhagat, J N Winter, H-Y Wang, S O'Neill, C H Dunphy, E D Hsi, X F Zhao, R S Go, W W L Choi, F Zhou, M Czader, J Tong, X Zhao, J H van Krieken, Q Huang, W Ai, J Etzell, M Ponzoni, A J M Ferreri, M A Piris, M B Møller, C E Bueso-Ramos, L J Medeiros, L Wu & K H Young. (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26:9, pages 2103-2113.
Crossref
Crossref
Amir Mian, David Becton, Robert Saylors, Laura James, Xinyu Tang, Adnan Bhutta & Parthak Prodhan. (2012) Biomarkers for risk stratification of febrile neutropenia among children with malignancy: A pilot study. Pediatric Blood & Cancer 59:2, pages 238-245.
Crossref
Crossref
Charles H Lawrie, Erica Ballabio, Elizabeth Soilleux, James Sington, Christian S R Hatton, Stephan Dirnhofer & Alexandar Tzankov. (2012) Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma staining. Histopathology 61:1, pages 18-25.
Crossref
Crossref
L Brault, T Menter, E C Obermann, S Knapp, S Thommen, J Schwaller & A Tzankov. (2012) PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma. British Journal of Cancer 107:3, pages 491-500.
Crossref
Crossref
Rebecca C. Stacy, Frederick A. Jakobiec, Martina C. Herwig, Lynn Schoenfield, Arun Singh & Hans E. Grossniklaus. (2012) Diffuse Large B-Cell Lymphoma of the Orbit: Clinicopathologic, Immunohistochemical, and Prognostic Features of 20 Cases. American Journal of Ophthalmology 154:1, pages 87-98.e1.
Crossref
Crossref
Young Wha KohHyo Jeong KangChansik ParkDok Hyun YoonShin KimCheolwon SuhHeounjeong Go, Ji Eun Kim, Chul-Woo Kim & Jooryung Huh. (2012) The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages. The Oncologist 17:6, pages 871-880.
Crossref
Crossref
A Tefferi, A Pardanani, N Gangat, K H Begna, C A Hanson, D L Van Dyke, D Caramazza, A M Vannucchi, E Morra, M Cazzola, A Pereira, F Cervantes & F Passamonti. (2012) Leukemia risk models in primary myelofibrosis: an International Working Group study. Leukemia 26:6, pages 1439-1441.
Crossref
Crossref
Luis F. Porrata, Kay Ristow, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz S. Nowakowski, Carrie Thompson & Svetomir N. Markovic. (2012)
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte‐predominant
H
odgkin lymphoma
. British Journal of Haematology 157:3, pages 321-330.
Crossref
Crossref
William Sterlacci, Dominik Wolf, Spasenija Savic, Wolfgang Hilbe, Thomas Schmid, Herbert Jamnig, Michael Fiegl & Alexandar Tzankov. (2012) High transforming growth factor β expression represents an important prognostic parameter for surgically resected non–small cell lung cancer. Human Pathology 43:3, pages 339-349.
Crossref
Crossref
William Sterlacci, Alexandar Tzankov, Lothar Veits, Bettina Zelger, Michel P. Bihl, Anja Foerster, Florian Augustin, Michael Fiegl & Spasenija Savic. (2011) A Comprehensive Analysis of p16 Expression, Gene Status, and Promoter Hypermethylation In Surgically Resected Non-small Cell Lung Carcinomas. Journal of Thoracic Oncology 6:10, pages 1649-1657.
Crossref
Crossref
Alexandar Tzankov, Ulrich Strasser, Stephan Dirnhofer, Thomas Menter, Caroline Arber, Martine Jotterand, Alicia Rovo, Andre Tichelli, Reinhard Stauder & Ursula Günthert. (2011) In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival. Annals of Hematology 90:8, pages 901-909.
Crossref
Crossref
Bridget S Wilkins. (2011) Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues. Journal of Clinical Pathology 64:6, pages 466-476.
Crossref
Crossref
William Sterlacci, Alexandar Tzankov, Lothar Veits, Wilhelm Oberaigner, Thomas Schmid, Wolfgang Hilbe & Michael Fiegl. (2011) The Prognostic Impact of Sex on Surgically Resected Non–Small Cell Lung Cancer Depends on Clinicopathologic Characteristics. American Journal of Clinical Pathology 135:4, pages 611-618.
Crossref
Crossref
Zi Chen, Zunguo Du, Jieqing Chen, Zhongqing Chen, Yun Bao & Feng Tang. (2010) Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study. Medical Oncology 28:1, pages 241-248.
Crossref
Crossref
V.A. Farias, J.L. Linares-Fernández, J.L. Peñalver, J.A. Payá Colmenero, G.O. Ferrón, E.L. Duran, R.M. Fernández, E.G. Olivares, F. O’Valle, A. Puertas, F.J. Oliver & J.M. Ruiz de Almodóvar. (2011) Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta 32:1, pages 86-95.
Crossref
Crossref
William Sterlacci, Michael Fiegl, Wolfgang Hilbe, Herbert Jamnig, Wilhelm Oberaigner, Thomas Schmid, Florian Augustin, Jutta Auberger, Ellen C. Obermann & Alexandar Tzankov. (2010) Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients. Journal of Thoracic Oncology 5:9, pages 1325-1336.
Crossref
Crossref
Annette Hollmann, Raquel Aloyz, Kristi Baker, Stephan Dirnhofer, Trevor Owens, Robert Sladek & Alexandar Tzankov. (2010) Vav‐1 expression correlates with NFκB activation and CD40‐mediated cell death in diffuse large B‐cell lymphoma cell lines. Hematological Oncology 28:3, pages 142-150.
Crossref
Crossref
Ellen Christina Obermann, Caroline Arber, Martine Jotterand, Andre Tichelli, Petra Hirschmann & Alexandar Tzankov. (2010) Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia. Annals of Hematology 89:7, pages 663-669.
Crossref
Crossref
J. Han van Krieken. (2010) New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010. Journal of Hematopathology 3:1, pages 47-58.
Crossref
Crossref
Alexandar Tzankov, Matthias S. Matter & Stephan Dirnhofer. (2010) Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma. Pathobiology 77:6, pages 301-308.
Crossref
Crossref